Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2006
05/16/2006US7045363 Nucleotide-protein fusion; for use as a diagnostic tool in the decision of preferential particles
05/16/2006US7045362 Device and method for detecting organic molecules in a test substance
05/16/2006US7045361 a 2-(acridinylmethylaminomethyl)phenyl boronate in a polymeric matrix; fluorescence at wavelengths above 500 nm; in vivo glucose concentration analysis
05/16/2006US7045360 Method for analysis of reaction products
05/16/2006US7045359 Method and apparatus to detect a gas by measuring ozone depletion
05/16/2006US7045358 Parallel reactor for sampling and conducting in situ flow-through reactions and a method of using same
05/16/2006US7045353 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
05/16/2006US7045352 Detection of mutation in preferential nucleotide sequences; obtain cells, fuse, recover hybrids, monitor gene activity in hybrids, detect aberrant gene activity
05/16/2006US7045342 Diagnostic detection device and method
05/16/2006US7045329 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
05/16/2006US7045312 Method of monitoring a biological system by labeling with an apo metal binding protein
05/16/2006US7045311 Whole cell assay systems for cell surface proteases
05/16/2006US7045310 Measuring the concentration of preferential analyte in sample; obtain samples, incubate with binding particles, determine concentration of detectable particles
05/16/2006US7045309 9-substituted adenine derivatives as prodrug regulators of cell and tissue function
05/16/2006US7045308 Modulators of leukocyte activation, compositions and methods of use
05/16/2006US7045307 Method for measuring no synthase activity
05/16/2006US7045306 assay comprising transcriptional and cognate activators with Huntington's disease mutant protein; linked to detectable sequence within neuron; for preventing or treating a neurodegenerative disease associated with an expanded polyglutamine tract
05/16/2006US7045305 targeting probes in living microorganisms or cells by expressing Golgi membrane polypeptide comprising single chain antibody binding ligand that is contacted with a probe/ligand conjugate; detection by fluorescent cell sorting, nuclear magnetic resonance and positron emission tomography
05/16/2006US7045304 Contacting a first cell with the compound, determining a first value of a property of the first cell, contacting second cell containing zinc finger protein which modulates expression of the molecular target, determining second value of the cell
05/16/2006US7045303 cell-based assays designed to identify compounds that regulate the activity of polycystin; increased adherence to type I collagen coated surfaces; apical expression of NaK-ATPase on the cell membrane
05/16/2006US7045302 Expressed ligand-vascular intercellular signaling molecule
05/16/2006US7045300 Isolated, purified plant extract; anticancer agents; bonding n-acetylneuraminic acid to protein
05/16/2006US7045299 Digestive diseases; amino acid sequence 20 or 21; specific to orphan receptor protein ZAQ
05/16/2006US7045298 Method for identifying or screening agonist and antagonist to PPAR
05/16/2006US7045297 Detection of neurodegradation disease in humans, animals; measuring concentration of prion protein
05/16/2006US7045296 Process for analyzing protein samples
05/16/2006US7045294 Isolated human protease; screening for reduction of gene expression; therapy for dietetics, obesity, antidiabetic agents, cardiovascular disorders
05/16/2006US7045290 Prevention protein misfolding; central nervous system disorders; Alzheimer's, Parkinson's, Huntington's disease therapy
05/16/2006US7045288 Analyzing temperature profiles; heating, cooling block; controllers; using robots
05/16/2006US7045287 Method for contacting fluid components with moieties on a surface
05/16/2006US7045286 Detecting expression of preferential proteins in sample; immbolize particle expressing protein, incubate with indicator, amplify oligonucleotides, mix with fluorescent dye, measure fluorescence from stained oligonucleotide
05/16/2006US7045283 Detecting preferential ligands in cell; obtain cell, incubate with reporter molecules, detect reporter in cell
05/16/2006US7045282 Measurement using urinary catalytic iron; administering iron chelate
05/16/2006US7045281 Measuring induction of calcium mobilization by serotonin in growth arrested tissues
05/16/2006US7045280 Assay method
05/16/2006US7045152 Pulmonary disorders in which the S-nitrosoglutathione(GSNO) pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung an agent causing repletion of GSNO
05/16/2006US7045098 Device for use in separation of impurities from urogenital waste secretions
05/16/2006US7045097 Self- addressable, self-assembling microelectronic systems for carrying out and controlling multi-step and multiplex reactions in microscopic formats; for monitoring biological reactions
05/16/2006US7045049 Method of manufacture of colloidal rod particles as nanobar codes
05/16/2006US7045047 Gas sensor element
05/16/2006US7045046 Sensor connection means
05/16/2006US7044919 Test methods, devices and test kits
05/16/2006US7044707 Machine for displacement of receptacles in front of inspection stations
05/16/2006US7044010 Continuous fluid sampler and method
05/16/2006US7043990 System for and method of performing evaluation techniques on a log or round timber
05/16/2006US7043967 Sensor device for monitoring the condition of a fluid and a method of using the same
05/16/2006US7043958 Gas analyzer automated purge/zero process
05/16/2006US7043821 Method of preventing short sampling of a capillary or wicking fill device
05/16/2006CA2450081C Method and system for producing a moisture content map for use in moisture sorting green veneer using light transmission
05/16/2006CA2353033C Improvements in or relating to gas sensors
05/16/2006CA2276768C Gyratory shear press
05/16/2006CA2263976C Devices incorporating filters for filtering fluid samples
05/16/2006CA2129183C Bispecific trigger molecules recognizing lymphocyte antigen cd2 and tumor antigens
05/15/2006CA2526581A1 Method of assessing skin and overall health of an individual
05/11/2006WO2006050491A2 Methods for antibody engineering
05/11/2006WO2006050352A1 Blood test prototypes and methods for the detetion of circulating tumor and endothelial cells
05/11/2006WO2006050333A2 Methods and compositions for modulating apoptosis
05/11/2006WO2006050257A2 Detection of ion channel or receptor activity
05/11/2006WO2006050164A1 Analysis for glucose products using pyridinylboronic acid
05/11/2006WO2006050130A2 Glycan analysis using deuterated glucose
05/11/2006WO2006049969A2 Simultaneous detection of vitamins d2 and d3 using lc-ms/ms
05/11/2006WO2006049789A1 Intraoperative method for isolating and concentrating autologous growth factors and for forming residual autologous growth factor compositions
05/11/2006WO2006049514A1 Timber harvesting apparatus
05/11/2006WO2006049498A1 Means and methods for isolating and/or identifying a target molecule
05/11/2006WO2006049300A1 Method of detecting platelet thrombosis or organ injury
05/11/2006WO2006049289A1 Method of detecting target substances
05/11/2006WO2006049273A1 Method of efficiently screening protein capable of specific binding to ligand
05/11/2006WO2006049200A1 Membrane filter for microbe detection
05/11/2006WO2006049041A1 Bioassay equipment and bioassay method
05/11/2006WO2006049033A1 Method of checking indoor environment
05/11/2006WO2006048576A1 Method for preparing specific affinity anti-progesterone antibodies, the obtained antibodies and the use thereof for in vitro diagnosis
05/11/2006WO2006048556A1 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof
05/11/2006WO2006048491A1 Biosensor based on peptide nucleic acid (pna) molecules on gold surfaces, production method thereof and uses of same
05/11/2006WO2006048473A1 β-LACTAMIC RGD CYCLOPEPTIDES CONTAINING GAMMA (Ϝ) TURNS
05/11/2006WO2006048467A2 Animal models comprising at least one transgene and one sequence enabling the controlled expression of an rna interfering with this transgene
05/11/2006WO2006048447A1 Device and method for measuring cell properties
05/11/2006WO2006048418A1 Method and system for production metering of oil wells
05/11/2006WO2006048338A1 Cftr as a component of an autophagy signaling pathway, applications thereof to autophagic diseases, and determination of cystic fibrosis as an autophagic disease
05/11/2006WO2006048306A1 Structured copolymer supports for use in mass spectrometry
05/11/2006WO2006048298A1 Screening method for the early diagnosis of cerebral vasospasm
05/11/2006WO2006048270A2 Methods of detecting leukemia and its subtypes
05/11/2006WO2006048234A2 Diagnosis and therapy of autophagy-associated diseases
05/11/2006WO2006048164A1 Aptamer-based test system
05/11/2006WO2006047928A1 Preparation and application of the type of cell detecting immunoassaying chips for cancer and their use
05/11/2006WO2006047911A1 A type of high-throughput biochip and its application
05/11/2006WO2006047869A1 Disposable immunodiagnostic test system
05/11/2006WO2006047840A1 Method for transport of magnetic particles and devices therefor
05/11/2006WO2006034102A3 Biological test strip
05/11/2006WO2006032809A3 Method for detecting streptococcus agalactiae using esterase activity
05/11/2006WO2006031663A3 Methods for detecting targets
05/11/2006WO2006018811B1 A bio-electronic device
05/11/2006WO2006015797A3 Method for high-throughput screening of test molecules binding to target molecules
05/11/2006WO2006013472A3 Novel anti-igf-ir antibodies and uses thereof
05/11/2006WO2006012884B1 Device and method for isolating cells, bioparticles and/or molecules from liquids designed to be used for the treatment of human diseases
05/11/2006WO2006009765A3 Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
05/11/2006WO2005121788A3 Method for the early detection of renal disease and injury
05/11/2006WO2005121780A3 Methods and apparatus for characterizing, measuring, and dispensing fluids
05/11/2006WO2005118833A3 Diagnostics and therapeutics for diseases associated with sterile-alpha motif and leucine zipper containing kinase (zak)
05/11/2006WO2005117994A3 Bmp pathway methods and compositions
05/11/2006WO2005117556A3 Quantitative lateral flow system and assay